HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ethanol extracts of Rhaponticum uniflorum (L.) DC inflorescence ameliorate LPS-mediated acute lung injury by alleviating inflammatory responses via the Nrf2/HO-1 signaling pathway.

AbstractETHNOPHARMACOLOGICAL RELEVANCE:
Rhaponticum uniflorum (L.) DC is a member of the Compositae family. Loulu flowers (LLF) is the inflorescence of this plant, which is a commonly used Mongolian medicine for the treatment of inflammatory diseases due to its heat-clearing and detoxifying properties. It is used caused by. However, its anti-inflammatory mechanisms are not clear.
AIM OF THIS STUDY:
We investigated whether ethanol extracts of LLF can alleviate LPS-induced acute lung injury and explored the mechanism involved.
MATERIAL AND METHODS:
BALB/C mice were intragastrically administered with sodium carboxymethyl cellulose (0.5%, 1 mL/100 g) or ethanol extracts of LLF at a dose of 100, 200, and 400 mg/kg, once daily, for 3 days. Subsequently, mice models of acute lung injury were established by LPS and used for the determination of anti-inflammatory effects of LLF. After 6 h of treatment, mice were sacrificed to collect lung tissues and bronchoalveolar lavage fluid (BALF). H&E staining assay was performed on the tissues for pathological analysis. The ELISA test was conducted to measure NO, IL-6, TNF-α, MPO, SOD, CAT, MDA and GSH-PX levels. The expression level of proteins associated with the Nrf2/HO-1 and MAPK/NF-κB signaling pathways were determined using Western blot analysis. Levels of F4/80 and Nrf2 in lungs were quantified using immunohistochemistry.
RESULTS:
Oral administration of LLF extracts alleviated LPS-induced pathological alterations, reduced lung W/D weight ratio, decreased levels of TP, pro-inflammatory factors (TNF-α and IL-6), and NO in BALF. Pretreatment with LLF extract downregulated F4/80 expression in lung tissue and suppressed LPS-induced elevations in BALF and lung tissue levels of MPO. Moreover, treatment with LLF extract reduced the expression level of proteins associated with the MAPK signaling pathway (p-p38, p-JNK, p-ERK) and TLR4/NF-κB signaling pathways (TLR4, Myd88, p-IκB, p-p65). Moreover, LLF extract upregulated Nrf2, HO-1 and NQO1 protein levels, downregulated Keap1 protein level. Immunohistochemical analysis revealed that LLF reduced the LPS-induced increase in Nfr2 expression in lung tissues.
CONCLUSION:
Ethanol extracts of LLF ameliorated LPS-induced acute lung injury by suppressing inflammatory response and enhancing antioxidation capacity, which correlated with the MAPK/NF-κB and Nfr2/HO-1 signaling pathways.
AuthorsDong Zhen, Chunyan Liu, Tianpeng Huang, Danni Fu, Xue Bai, Qianqian Ma, Mingyang Jiang, Guohua Gong
JournalJournal of ethnopharmacology (J Ethnopharmacol) Vol. 296 Pg. 115497 (Oct 05 2022) ISSN: 1872-7573 [Electronic] Ireland
PMID35738472 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Interleukin-6
  • Kelch-Like ECH-Associated Protein 1
  • Lipopolysaccharides
  • Membrane Proteins
  • NF-E2-Related Factor 2
  • NF-kappa B
  • Plant Extracts
  • Toll-Like Receptor 4
  • Tumor Necrosis Factor-alpha
  • Ethanol
  • Heme Oxygenase-1
  • Hmox1 protein, mouse
Topics
  • Acute Lung Injury (chemically induced, drug therapy, metabolism)
  • Animals
  • Anti-Inflammatory Agents
  • Asteraceae (chemistry)
  • Ethanol
  • Heme Oxygenase-1 (metabolism)
  • Inflammation (chemically induced, drug therapy, metabolism)
  • Inflorescence
  • Interleukin-6 (metabolism)
  • Kelch-Like ECH-Associated Protein 1 (metabolism)
  • Leuzea (chemistry)
  • Lipopolysaccharides (toxicity)
  • Membrane Proteins (metabolism)
  • Mice
  • Mice, Inbred BALB C
  • NF-E2-Related Factor 2 (metabolism)
  • NF-kappa B (metabolism)
  • Plant Extracts (chemistry, pharmacology, therapeutic use)
  • Signal Transduction
  • Toll-Like Receptor 4 (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: